Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -203,654 | -65,276 | -615,117 | -499,144 | -335,731 |
| Depreciation Amortization | 11,652 | 4,755 | 10,745 | 4,915 | -1,980 |
| Income taxes - deferred | -363 | N/A | -1,063 | N/A | N/A |
| Accounts receivable | N/A | N/A | -565 | 3,041 | 3,041 |
| Accounts payable and accrued liabilities | -2,158 | 735 | 732 | -1,895 | 5,630 |
| Other Working Capital | -83,814 | -82,147 | -304,591 | -271,843 | -242,150 |
| Other Operating Activity | 91,100 | 32,543 | 131,074 | 94,068 | 56,161 |
| Operating Cash Flow | $-187,237 | $-109,390 | $-778,785 | $-670,858 | $-515,029 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 241,653 | 29,759 | 186,202 | 289,478 | 344,718 |
| PPE Investments | -1,626 | -1,339 | -21,573 | -20,038 | -16,324 |
| Investing Cash Flow | $240,027 | $28,420 | $164,629 | $269,440 | $328,394 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -69 | -287 | -200 | -134 |
| Common Stock Issued | 3,232 | 221 | 7,767 | 6,000 | 5,657 |
| Other Financing Activity | -138 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $3,094 | $152 | $7,480 | $5,800 | $5,523 |
| Beginning Cash Position | 261,292 | 261,292 | 867,968 | 867,968 | 867,968 |
| End Cash Position | 317,176 | 180,474 | 261,292 | 472,350 | 686,856 |
| Net Cash Flow | $55,884 | $-80,818 | $-606,676 | $-395,618 | $-181,112 |
| Free Cash Flow | |||||
| Operating Cash Flow | -187,237 | -109,390 | -778,785 | -670,858 | -515,029 |
| Capital Expenditure | -2,538 | -1,872 | -21,573 | -20,038 | -16,324 |
| Free Cash Flow | -189,775 | -111,262 | -800,358 | -690,896 | -531,353 |